BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 16820607)

  • 1. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
    Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts.
    Mehta RH; Honeycutt E; Shaw LK; Glower D; Harrington RA; Sketch MH
    Am Heart J; 2006 Oct; 152(4):801-6. PubMed ID: 16996861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions.
    Mehta RH; Honeycutt E; Shaw LK; Sketch MH
    Am Heart J; 2008 Oct; 156(4):728-35. PubMed ID: 18926154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
    Goldman S; Zadina K; Moritz T; Ovitt T; Sethi G; Copeland JG; Thottapurathu L; Krasnicka B; Ellis N; Anderson RJ; Henderson W;
    J Am Coll Cardiol; 2004 Dec; 44(11):2149-56. PubMed ID: 15582312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategy for post coronary artery bypass grafting in patients with bypass graft stenosis: comparison of percutaneous transluminal coronary angioplasty for the native coronary artery, internal mammary artery and saphenous vein graft].
    Kawaguchi R; Hoshizaki H; Oshima S; Ito S; Hiratsuji T; Tsurugaya H; Ito I; Sekiguchi M; Takama N; Seta Y; Adachi H; Toyama T; Naito S; Kaneko T; Taniguchi K
    J Cardiol; 2001 Nov; 38(5):239-44. PubMed ID: 11729723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention.
    Gruberg L; Weissman NJ; Pichard AD; Waksman R; Kent KM; Satler LF; Suddath WO; Pinnow EE; Gevorkian N; Lindsay J
    Am Heart J; 2003 Mar; 145(3):529-34. PubMed ID: 12660678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive endarterectomy of the left anterior descending coronary artery combined with coronary artery bypass grafting.
    Christenson JT; Simonet F; Schmuziger M
    Coron Artery Dis; 1995 Sep; 6(9):731-7. PubMed ID: 8747879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single versus bilateral internal mammary artery for isolated first myocardial revascularization in multivessel disease: long-term clinical results in medically treated diabetic patients.
    Calafiore AM; Di Mauro M; Di Giammarco G; Teodori G; Iacò AL; Mazzei V; Vitolla G; Contini M
    Ann Thorac Surg; 2005 Sep; 80(3):888-95. PubMed ID: 16122450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypass grafts to the left anterior descending coronary artery: saphenous vein versus internal mammary artery.
    Tyras DH; Barner HB; Kaiser GC; Codd JE; Pennington DG; Willman VL
    J Thorac Cardiovasc Surg; 1980 Sep; 80(3):327-33. PubMed ID: 6968006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of exclusive use of in situ arterial conduits over combined use of arterial and vein grafts for multiple coronary artery bypass grafting.
    Nishida H; Tomizawa Y; Endo M; Kurosawa H
    Circulation; 2005 Aug; 112(9 Suppl):I299-303. PubMed ID: 16159835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection.
    Morrison DA; Thai H; Goldman S; Felix E; Hernandez J
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):571-9. PubMed ID: 16547927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operation for two-vessel coronary artery disease: midterm results of bilateral ITA grafting versus unilateral ITA and saphenous vein grafting.
    Carrel T; Horber P; Turina MI
    Ann Thorac Surg; 1996 Nov; 62(5):1289-94. PubMed ID: 8893559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis.
    Kachhy RG; Kong DF; Honeycutt E; Shaw LK; Davis RD
    Circulation; 2006 Jul; 114(1 Suppl):I425-9. PubMed ID: 16820612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.
    Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Ben-Dor I; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):23-9. PubMed ID: 21061247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival.
    Stevens LM; Carrier M; Perrault LP; Hébert Y; Cartier R; Bouchard D; Fortier A; El-Hamamsy I; Pellerin M
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1408-15. PubMed ID: 15116000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting.
    Stevens LM; Carrier M; Perrault LP; Hébert Y; Cartier R; Bouchard D; Fortier A; Pellerin M
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):281-8. PubMed ID: 15691683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.